Iranian Journal of Parasitology 2015. 10(3):306-328.

The Status of Human and Animal Fascioliasis in Iran: A Narra¬tive Review Article
Keyhan ASHRAFI

Abstract


Background: The public health importance of human fascioliasis has increased during last few decades due to the appearance of new emerging and re-emerging foci in many countries. Iran, as the most important focus of human disease in Asia, has been included among six countries known to have a serious problem with fascio­liasis by WHO. Various aspects of the disease in Iran are discussed in this review.

Methods: This narrative review covers all information about human and animal fascioliasis in Iran, which has been published in local and international journals from 1960 to 2014 using various databases including PubMed, SID, Google Scholar, Scopus, Science Direct.

Results: During the period of the study the infection rates of 0.1% to 91.4% was noted in various livestock. Despite the higher infection rates of livestock in south­ern areas in past decades, human disease has been mostly encountered in northern Provinces especially in Guilan. Recent studies indicate noticeable decrease in preva­lence rates of veterinary fascioliasis in Iran, however the prevalence rates of fascio­liasis in livestock in northern Provinces of Guilan and Mazandaran seem to remain at a higher level in comparison to other parts. New foci of the disease have also been reported recently. 

Conclusion: While the prevalence of animal fascioliasis has decreased during last decades, human fascioliasis emerged as a public health problem in the country. The validity of new foci of human fascioliasis needs complementary standard studies.

Keywords


Human fascioliasis; Animal fascioliasis; Epidemiology; Lym-naeid snails; Iran

Full Text:

PDF

References


Mas-Coma S, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a re-view and proposed new classification. Bul-letin of the World Health Organiza-tion.1999; 77 (4):340–346.

Haswell-Elkins MR, Elkins DB. Food-borne Trematodes, in: Cook, G.C. (ed.), Manson’s Tropical Diseases. London: Saunders; 1996. p. 1461-1464.

Chen MG, Mott KE. Progress in assess-ment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull. 1990; 87(4):R1-R38.

Rim HJ, Farag HF, Sornmani S, Cross JH. Food-borne trematodes: ignored or emerg-ing? Parasitol Today. 1994; 10:207-209.

World Health Organization. Control of food-borne trematode infections. WHO Technical Report Series. 1995; 849:1-157.

Hopkins DR. Homing in on helminthes. Am J Trop Med Hyg. 1992; 46(6):626-634.

Mas-Coma S. Human fascioliasis: Epide-miological patterns in human endemic are-as of South America, Africa and Asia. Southeast Asian J Trop Med Public Health. 2004; 35(S1):1-11.

Mas-Coma S, Angles R, Esteban JG, Bargues MD, Buchon P, Franken M, Strauss W. The Northern Bolivian Alti-plano: a region highly endemic for human fascioliasis. Trop Med Intl Health. 1999; 4(6):454–467.

Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trema-tode zoonoses. Int J Parasitol, 2005; 35(11-12):1255-1278.

Mas-Coma S, Valero MA, Bargues MD. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmis-sion, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009; 69, 41-146.

World Health Organization. The "ne-glected" neglected worms. Action against Worms. 2007; 10:1-8.

Hanjani AA, Nikakhtar B, Arfaa F, Kha-kpour M, Rashed MA. A case of infection with Fasciola hepatica with allergic manifesta-tions. Acta Medica Iranica. 1971; 14:149-151.

Farid-Moayer H. Human infection with Fasciola hepatica and Dicrocoelium dendriticum in Isfahan area, central Iran. J Parasitol. 1971; 2:160.

Massoud J. Fascioliasis outbreak in man and drug test (Triclabendazole) in Caspian Sea Littoral, Northern part of Iran. Bull Soc France Parasitol. 1989; 8(S1):438-439.

Asmar M, Milaninia A, Amir-Khani A, Yadegari D, Forghan-Parast K, Nahrava-nian H, Piazak N, Esmaeili A, Hovanesian A, Valadkhani Z. Seroepidemiological in-vestigation of fascioliasis in northern Iran. Med J Islamic Repub Iran. 1991; 5(1-2):23-27.

Mas-Coma S. Parasitic diseases, global change and the developing world: the ex-ample of emerging fascioliasis. Scientia Par-asitologica, 2007; 1:10-21.

Moghaddam A, Massoud J, Mahmoodi M, Mahvi AH, Periago MV, Artigas P, Fuentes MV, Bargues MD, Mas-Coma S. Human and animal fascioliasis in Mazandaran Province, northern Iran. Parasitol Res. 2004; 94 (1):61-69.

Emami Al-Agha M, Athari A. Subcutane-ous fascioliasis: a rare complication. Med J Islamic Repub Iran. 1995; 8(4):260-270.

Hatami H, Asmar M, Massoud J, Mansouri F, Namdaritabar H, Ramazankhani A. The first epidemic and new emerging human fascioliasis in Kermanshah, western Iran, and a ten-year follow up, 1998-2008. Int J Prev Med. 2012; 3(4):266-72.

Sarkari B, Ghobakhloo N, Moshfea AA, Eilami O. Seroprevalence of human fascio-liasis in a new-emerging focus of fascio-liasis in Yasuj district, southwest of Iran. Iran J Parasitol. 2012; 7(2):15-20.

Mowlavi G, Mamishi S, Rokni MB, Mobedi I, Gharaguzlo MJ, Ashrafi K, Mas-Coma S. Neglected human fascioliasis case in a vis-ceral leishmaniasis endemic area, north-western Iran. Iran J Public Health. 2010; 39(3):129-131.

Mohammadi-Ghalehbin, B, Chinifroush-Asl MM, Ramzi F. Extra-hepatic fascio-

liasis with peritoneal malignancy tumor fea-ture. J Parasit Dis. 2012; 36(1):78-80.

Asadian S, Mohebali M, Mahmoudi M, Kia EB, Heidari Z, Asghari M, Aryaeipour M, Moradi S, Rokni MB. Seroprevalence of human fascioliasis in Meshkin-Shahr dis-trict, Ardabil Province, northwestern Iran in 2012. Iran J Parasitol. 2013; 8(4): 2013.

Dowlati Y, Dowlati A, Seyyedi BV. Cuta-neous fascioliasis. Med J Islamic Repub Iran. 1987; 1:62-65.

Sanei-Taheri M, Aminzade Z, Shokohi S, Aghazade K. Hepatobiliary fascioliasis: clinical and radiological features. Iran J Parasitol. 2007; 2(4):48-55.

Moghadami M, Mardani M. Fasciola hepatica: A cause of obstructive jaundice in an el-derly man from Iran. The Saudi J Gastro-enterol. 2008; 14(4):208-210.

Aminian K, Akhavan-Rezayat K, Shafaghi A, Tanhaeevash. Living Fasciola hepatica in biliary tree: a case report. Ann Hepatol. 2012; 11(3):395-398.

Alavi-Naini R, Sharifi-Mood B, Khazaei AR, Khorgami P. A case of fascioliasis from southeast of Iran. Zahedan J Res Med Sci. 2013; 15(12):40-41.

Dalimi A, Jabarvand M. Fasciola hepatica in the human eye. Trans R Soc Trop Med Hyg. 2005; 99(10):798-800.

Riazi H. Large liver abscess: Unusual presentation of fascioliasis: case report and literature review. The Saudi J Gastroenterol. 2001; 7(3):113-115.

Behzad C, Lahmi F, Iranshahi M, Mo-hammad Alizadeh AH. Finding of biliary fascioliasis by endoscopic ultrasonography in a patient with eosinophilic liver abscess. Case Rep Gastroenterol. 2014; 8(2):310-8.

Esmaeili M, Khatami G, Najafi M, Khoda-dad A. Fascioliasis in a child with ascites treated with triclabendazole. J Babol Univ Med Sci. 2002; 4(2):44-47. [In Persian].

Mansouri D, Jamshidi-Fard A. A case re-port of fascioliasis with rare manifestations of recurrent fever and ascites. J Babol Univ Med Sci. 2002; 4(4):50-54. [In Persian].

Zali MR, Ghaziani T, Shahraz S, Hek-matdoost A, Radmehr A. Liver, spleen, pancreas and kidney involvement by hu-man fascioliasis: imaging findings. BMC Gastroenterol. 2004; 4:15.

Esteban JG, Flores A, Angles R, Mas-Coma S. High endemicity of human fascio-liasis between Lake Titicaca and La Paz val-ley, Bolivia. Tran R Soc Trop Med Hyg. 1999; 93(2):151–156.

Esteban JG, González C, Bargues MD, Angles R, Sánchez C, Naquira C, Mas Co-ma S. High fascioliasis infection in children linked to a man-made irrigation zone in Pe-ru. Trop Med Int Health. 2002; 7(4):339–348.

Esteban JG, Gonzalez C, Curtale F, Munoz-Antoli C, Valero MA, Bargues MD, El Sayed M, El Wakeel A, Abdel-Wahab Y, Montresor A, Engels D, Savioli L, Mas-Coma. Hyperendemic fascioliasis associ-ated with schistosomiasis in villages in the Nile Delta of Egypt. Am J Trop Med Hyg. 2003; 69(4):429–437.

Forghan-parast K, Yadegari D, Asmar M 1993. Clinical epidemiology of human fascioliasis in Guilan. J Guilan Univ Med Sci. 1993; 2(6-7):4-11. [In Persian].

Ashrafi K, Saadat F, O’Neill S, Rahmati B, Amin Tahmasbi H, Dalton JP, Nadim A, Asadinejhad M, Rezvani SM. The endemic-ity of human fascioliasis in Guilan Province, Northern Iran: the baseline for implemen-tation of control strategies. Iran J Public Health. 2015, 44(4):501-511

Bargues MD, Funatsu IR, Oviedo JA, Mas-coma S. Natural water, an additional source for human infection by Fasciola hepatica in the Northern Bolivian Altiplano. Parasito-logia. 1996; 38:251.

Ashrafi K, Bargues MD, O'Neill S, Mas-Coma S. Fascioliasis: A worldwide parasitic disease of importance in travel medicine. Travel Med Infect Dis. 2014; 12:636-649.

Ashrafi K, Valero MA, Massoud J, Sobhani A, Solaymani-Mohammadi S, Conde P, Khoubbane M, Bargues MD, Mas-Coma S. Plant-borne human contamination by fascioliasis. Am J Trop Med Hyg. 2006; 75(2):295-302.

Ashrafi K, Valero MA, Forghan-Parast K, Rezaeian M, Shahtaheri SJ, Hadiani MR, Bargues MD, Mas-Coma S. Potential trans-mission of human fascioliasis through tra-

ditional local foods in northern Iran. Iran J Public Health. 2006; 35(2):57-63.

Bargues MD, Mas-Coma S. Reviewing lymnaeid vectors of fascioliasis by riboso-mal DNA sequence analyses. J Helmintol. 2005; 79(3):257-267.

Ashrafi K, Massoud J, HolakueiNaieni K, Mahmoodi M, Jo-Afshani MA, Valero MA, Fuentes MV, Khoubbane M, Artigas P, Bargues MD, Mas-Coma S. Evidence sug-gesting that Fasciola gigantica might be the most prevalent causal agent of fascioliasis in the endemic Province of Guilan, north-ern Iran. Iran J Public Health. 2004; 33(4):31-37.

Ashrafi K, Massoud J, Holakouei Naeini K, Joafshani MA, Mahmoodi M, Ebadati N, Rezvani SM, Artigas P, Bargues MD, Mas-Coma S. Nuclear ribosomal DNA ITS-2 sequence characterization of Fasciola hepat-ica and Galba truncatula. Iran J Public Health. 2007; 36(4):42-49.

Salahi-Moghaddam A. Epidemiology of human fascioliasis in Iran. J Kerman Univ Med Sci. 2009; 16(4):385-398. [In Persian].

Karimi GR, Derakhshanfar M, Paykari H. Population density, trematodal infection and ecology of Lymnaea snails in Shadegan, Iran. Arch Razi Inst. 2004; 58:125-129.

Imani-Baran A, Yakhchali M, Malekzadeh-Viayah R, Farhangpajuh F. Prevalence of infection in Lymnaea auricularia (Linnaeus, 1758) in northwest of Iran. Vet Res Forum. 2011; 2(2):121-127.

Imani-Baran A, Yakhchali M, Malekzadeh-Viayah R. Geographical distribution and di-versity of Lymnaeidae snails in Western Azerbaijan Province, northwest of Iran. Pa-jouhesh va Sazandegi. 2011; 89:53-63 [In Persian].

Mansoorian A 2000. Some freshwater snails from northern Iran. Iran J Public Health. 2000; 29(1-4):77-82.

Hosseini SH, Vaezi V, Jafari G 2004. Epi-demiology of fasciolosis in Kermanshah Province. J vet Faculty Tehran Univ. 2004; 59(3):202-206. [In Persian].

Bargues MD, Artigas P, Khoubbane M, Flores R, Glöer P, Rojas-Garcia R, Ashrafi K, Falkner G, Mas-Coma S. Lymnaea schira-ziensis, an overlooked snail distorting fascioliasis data: genotype, phenotype, ecol-ogy, worldwide spread, susceptibility, ap-plicability. PLoS ONE. 2011; 6(9):1-33.

Massoud J, Sadjadi S. Susceptibility of dif-ferent species of Lymnaea snails to miracidia of Fasciola gigantica and F. hepatica in Iran. J Helminthol. 1980; 54(3):201-202.

Arfaa F, Movafagh K, Mahdavi M. Lymnaea gedrosiana, an intermediate host of Fasciola hepatica in Iran. J Parasitol. 1969; 55(1):134-35.

Rohani S, Massoud J. The effect of varia-tion in miracidial exposure dose on experi-mental infection of Fasciola gigantica in Lymnaea gedrosiana. Iran J Public Health. 1990; 19:1-4.

Shahlapour AA, Massoud J, Nazary JH, Rahnou MN. Further observations on the susceptibility of different species of Lymnaea snails of Iran to miracidia of Fasciola hepatica and Fasciola gigantica. Arch Razi Inst. 1994; 44:11-17.

Mas-Coma S, Bargues MD. Human liver flukes: a review. Res Rev Parasitol. 1997; 57(3-4):145-21.

Mas-Coma S, Funatsu IR, Bargues MD. Fasciola hepatica and lymnaeid snails occur-ring at very high altitude in South America. Parasitol. 2001; 123(S1):15-27.

Bargues MD, Vigo M, Horak P, Dvorak J, Patzner RA, Pointier JP, Jackiewicz M, Meier-Brook C, Mas-Coma S. European Lymnaeidae (Mollusca: Gastropoda), in-termediate hosts of trematodiases, based on nuclear ribosomal DNA ITS-2 se-quences. Infect Genet Evol. 2001; 1(2):85–107.

Cruz-Reyes A, Malek EA. Suitability of six lymnaeid snails for infection with Fasciola hepatica. Vet Parasitol. 1987; 24(3-4):203-10.

Ashrafi K, Mas-Coma S. Fasciola gigantica transmission in the zoonotic fascioliasis en-demic lowlands of Guilan, Iran: experi-mental assessment. Vet Parasitol. 2014; 205:96-106.

Ashrafi k 2005. Study of human and animal fascioliasis and determination of genotype and phenotype of fasciolids and their in-termediate hosts in Guilan Province. Dis-sertation. Tehran University of Medical Sci-ences, Tehran, Iran.

Bargues MD, Artigas P, Mera Y, Sierra RL, Pointier JP, Mas-Coma S. Characterization of Lymnaea cubensis, L. viatrix and L. neotropi-can. sp., the main vectors of Fasciola hepatica in Latin America, by analysis of their ribo-somal and mitochondrial DNA. Ann Trop Med Parasitol. 2007; 101(7): 621-41.

Salahi-Moghaddam A, Massoud J, Mahmoodi M, Khoubbane M, Artigas P, Periago MV, Fuentes MV, Bargues MD, Mas-Coma S. Distributional outline of lymnaeid snails (Gastropoda) in the fascio-liasis endemic area of Mazandaran, Iran. Acta Parasitologica. 2004; 49(2):134-141.

Boray JC. Fascioliasis. In: Steel JH, (Ed.), Zoonoses: Parasitic Zoonoses. Sect. C. Vol. III, CRC Handbook Series. 1982; p.71-88.

Boray JC, Happich FA, Andrews JC. The epidemiology of fascioliasis in two repre-sentative endemic regions of Australia. Australian Vet J. 1969; 45(12):549-53.

Ashrafi K, Valero MA, Panova M, Periago MV, Massoud J, Mas-Coma S. Phenotypic analysis of adults of Fasciola hepatica, F. gi-gantica and intermediate forms from the en-demic region of Guilan, Iran. Parasitol Int. 2006; 55:249-260.

Ashrafi K, Valero MA, Raquel VP, Artigas P, Panova M, Mas-Coma S (2015). Distri-bution of Fasciola hepatica and Fasciola gi-gantica in the endemic area of Guilan, Iran: relationships between zonal overlap and phenotypic traits. Infect Genet evol. 31:95-109.

Sahba GH, Arfaa F, Farahmandian I, Halali H. Animal fascioliasis in Khuzestan, south-western Iran. J Parasitol. 1972; 58(4):712-716.

Mahami-Oskouei M, Dalimi A, Forouzan-deh-Moghadam M, Rokni MB. Molecular identification and differentiation of Fasciola isolates using PCR- RFLP method based on Internal Transcribed Spacer (ITS1, 5.8S rDNA, ITS2). Iran J Parasitol. 2011; 6(3):35-42.

Amor N, Halajian A, Farjallah S, Merella P, Saeid K, Ben Slimane B. Molecular charac-terization of Fasciola spp. from the endemic area of northern Iran based on nuclear ri-bosomal DNA sequences. Exp Parasitol. 2011; 128(3):196-204.

Ghavami MB, Rahimi P, Haniloo A, Mo-savinasab SN. Genotypic and phenotypic analysis of Fasciola isolates. Iran J Parasitol. 2009; 4(3):61-70.

Shahbazi A, Akbarimoghaddam M, Izadi S, Ghazanchaii A, Jalali N, Bazmani A. Iden-tification and genetic variation of Fasciola species from Tabriz, northwestern Iran. Iran J Parasitol. 2011; 6(3):52-59.

Karimi A. Genetic diagnosis of Fasciola species based on 18S ribosomal DNA se-quence. J Biol Sci. 2008; 8(7):1166-1173.

Rokni MB, Mirhendi H, Mizani A, Mohe-bali M, Sharbatkhori M, Kia EB, Abdoli H, Izadi S. Identification and differentiation of Fasciola hepatica and Fasciola gigantica using a simple PCR-restriction enzyme method. Exp Parasitol. 2009; 124:209-213.

Sabokbar RD. Geographical distribution of Fasciola hepatica (sheep liver fluke) and its relationship with human distomatosis. J Medicine School of Tehran University. 1960; 17:251-260. [In Persian].

Sabbaghian H, Bijan H, Arfaa F. Data on trematode infections among livestock in Khuzestan, Iran. Bull Tehran Coll Vet Med. 1964; 2:12.

Eslami A, Hosseini SH, Meshgi B. Animal fascioliasis in north of Iran. Iran J Public Health. 2009; 38(4):132-135.

Hosseini SH, Jolokhani M, Bahonar AR, Eslami A. Cattle fascioliasis in Guilan prov-ince, Iran. Int J Vet Res. 2010; 4(1):57-60.

Hosseini SH, Meshgi B, Abbasi A, Eslami A 2012. Animal fascioliasis in coastal re-gions of the Caspian Sea, Iran (2006-2007). Iran J Vet Res Univ Shiraz. 2012; 13(1): 64-67.

Tavakoli HR, Mahmoodzadeh A, Hajia M. A five years study of fascioliasis and dicro-coeliasis in Iran's slaughterhouses. Asian Pacific J Trop Med. 2008; 1(4):9-13.

Khanjari A, Partovi R, Abbaszadeh S, Ne-mati G, Bahonar A, Misaghi A, Akhondza-deh-Basti A, Alizadeh-Basti A, Motaghifar A. A retrospective survey of fascioliasis and dicrocoeliasis in slaughtered animals in Meisam Abattoir, Tehran, Iran (2005-2008).Vet Res Forum. 2010; 1(3):174-178.

Daryani A, Alaei R, Arab R, Sharif M, Dehghan MH, Ziaei H. Prevalence of liver

fluke infections in slaughtered animals in Ardabil Province, northwestern Iran. J Anim Vet Adv. 2006; 5(5):408-411.

Ghazaei C. An abattoir survey of hydatid and liver fluke diseases in sheep and cattle in Ardabil abattoir, Ardabil state, Iran. J Animal Vet Adv. 2007; 6(5):595-596.

Movassagh-Ghazani MH, Valilou MR, Ah-madzadeh AR, Karami AR, Zirak K. The prevalence of sheep liver trematodes in the northwest region of Iran. Turkish J Vet Animal Sci. 2008; 32(4):305-307.

Yakhchali M, Ghobadi K. Survey of liver helminthes infection rate and economic loss in sheep in Urmia slaughterhouse. Iran Vet J. 2005; 10:60-66. [In Persian].

Eslami A. Veterinary Helminthology, Trematoda, 1st ed. Tehran University Pub-lications, Tehran, Iran, 1979.

Eslami A. Veterinary Helminthology, Trematoda, 4th ed. Tehran University pub-lications, Tehran, Iran, 2005.

Khosravi A, Babaahmady E. Epidemiology of Fasciola hepatica in Iran. Int J Biol. 2012; 4(4):86-90.

Abdi J, Taherikalani M, Asadolahi K. Prev-alence of helminth parasitic diseases in in-dustrial abattoir in Ilam Province, western Iran. Sky J Microbiol Res. 2013; 1(1):1-4.

Abdi J, Naserifar R, Rostami Nejad M, Mansouri V. New features of fascioliasis in human and animal infections in Ilam Prov-ince, Western Iran. Gastroenterol Hepatol Bed Bench. 2013; 6(3):152-5.

Sabzvarinezjad G. Prevalence of zoonotic liver trematodes in slaughtered animals in Khoramabad slaughterehouse. J Lorestan Univ Med Sci. 2007; 6(22);51-54 [In Per-sian].

Fallah M, Matini M, Kia EB, Mobedi I. Prevalence of zoonotic parasites (hydatid cyst, liver flukes and Sarcocystis) in slaugh-tered livestock in Hamadan slaughterhouse in 2010. J Hamadan Univ Med Sci. 2010; 17(3):5-12. [In Persian].

Noorbeh H, Abolghasemi H. Prevalence of hepatic trematodes in slaughtered livestock of Zarandieh in 2010-2011. J Modern Vet Res. 2012; 3(10):27-32. [In Persian].

Moshfe A, Bagheri M, Mohebi-Nobandegany Z. Prevalence of Fasciola he-patica in slaughtered livestock in Yasuj's slaughterhouse 2001-2002. J Armaghan-e-Danesh. 2003; 8(30):25-33 [In Persian].

Ahmadi NA, Meshkehkar M. Prevalence and long term trend of liver fluke infection in sheep, goats, and cattle slaughtered in Khuzestan, southwestern Iran. J Paramed Sci. 2010; 1(2):26-31.

Borji H, Parandeh S. The abattoir condem-nation of meat because of parasitic in-fection, and its economic importance: re-sults of a retrospective study in north-east-ern Iran. Ann Trop Med Parasitol. 2010; 104(8):641-47.

Gharib- Mombeni E, Gharib –Mombeni M, Soltani- Sadeh N. Study of prevalence and economic importance of liver flukes in sheep and cattle slaughtered in Ahwaz slaughterhouse. J Modern Vet Res. 2011; 3(8):43-47. [In Persian].

Molazadeh P, Zohoor A. Prevalence of liver Trematodes and hydatid cyst in ani-mals in the Jiroft slaughterhouse. J Res Health Sci. 2002; 1:17-22. [In Persian].

Ansari-Lari M, Moazzeni M. A retrospec-tive survey of liver fluke disease in live-stock based on abattoir data in Shiraz, south of Iran. Prev Vet Med. 2006; 73:93-96.

Oryan A, Mansourian M, Moazeni M, Ni-kahval B, Barband S. Liver distomatosis in cattle, sheep and goats of northeastern Iran. Glob Vet. 2011; 6(3):241-246

Mas-Coma S, Bargues MD, Marty AM, Neafie RC. Hepatic Trematodiases, In: Meyers, W.M., Neafie, R.C., Marty, A.M., Wear, D.J., (Eds.), Pathology of Infectious Diseases, Vol. 1 Helminthiases. Armed Forces Institute of Pathology and Ameri-can Registry of Pathology, Washington D.C., 2000; p. 69-99.

Mas-Coma S, Bargues MD, Esteban JG. Human Fasciolosis, In: Dalton, J.P., (ed.), Fasciolosis, CAB International Publishing, Wallingford, Oxon, UK, 1999; p. 411-434.

Malekianzade E, Khazaei S, Ramazani M, Solaymani H 2012. A fascioliasis case re-port accompanied with fever, abdominal pain and jaundice. Sci J Hamadan Uni Med Sci. 2012; 19:78-80. [In Persian].

Hillyer GV. Immunodiagnosis of human and animal fasciolosis, In Dalton, J.P., (ed.), Fasciolosis. CABI Publishing, Oxon, Wall-ingford, UK, 1998; p. 435–448

Espino AM, Dumeningo BE, Fernandez R, Finaly C. Immunodiagnosis of human fasciolosis by ELISA using excretory–secretory products. Am J Trop Med Hyg. 1987; 37(3):605–608.

Rokni MB, Massoud J, O’Neill SM, Parkin-son M, Dalton JP. Diagnosis of human fasciolosis in the Guilan Province of north-ern Iran: application of cathepsin L-ELISA. Diagn Microbiol Infect Dis. 2002; 44(2):175–179.

O’Neill SM, Parkinson M, Strauss W, An-gles R, Dalton JP. Immunodiagnosis of Fasciola hepatica infection (fasciolosis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine protein-ase. Am J Trop Med Hyg. 1998; 58(4):417–423.

Rahimi MT, Ashrafi K, Koosha S, Abdi J, Rokni MB. Evaluation of fast-ELISA ver-sus standard-ELISA to diagnose human fasciolosis. Arch Iran Med. 2011; 14(1):18-21.

Arjona R, Riancho JA, Aguado JM, Salesa R, Gonzalez-Macias J. Fascioliasis in devel-oped countries: a review of classic and ab-errant forms of the disease. Medicine (Bal-timore). 1995; 74(1):13–23.

Han JK, Choi BI, Cho JM, Chung KB, Han MC, Kim CW. Radiological findings of human fascioliasis. Abdom Imaging. 1993; 18(3):261–4.

Han JK, Han D, Choi BI, Han MC. MR findings in human fascioliasis. Trop Med Int Health. 1996; 1(3):367–72.

Kabaalioglu A, Ceken K, Saba R, Artan R, Cevikol C, Yilmaz S. Pediatric fascioliasis: report of three cases. Turkish J Pediatr. 2003; 45(1):51-54.

Price TA, Tuazon CU, Simon GL. Fascio-liasis: case reports and review. Clin Infect Dis. 1993; 17(3):426–30.

Mohammad Alizadeh AH, Roshani M, Lahmi F, Davoodi NA, Rostami Nejad M, Seyyedmajidi MR, Zali MR. Cholangiocar-cinoma in magnetic resonance cholangi-opancreatography and fascioliasis in endo-scopic ultrasonography. Case Rep Gastro-enterol. 2011; 5(3):569-77.

Mansour Ghanaei F, Alizadeh A, Pourra-souli Z, Vahidi H, Naghipour MR. So-nographic findings of human fascioliasis. Iran J Radiol. 2006; 4(1):11-15.

Bassiouny HK, Soliman NK, el-Daly SM, Badr NM. Human fascioliasis in Egypt: ef-fect of infection and efficacy of bithionol treatment. J Trop Med Hyg. 1991; 94(5):333-337.

Bacq Y, Besnier JM, Duong TH, Pavie G, Metman EH, Choutet P. Successful treat-ment of acute fascioliasis with bithionol. Hepatol. 1991; 14(6):1066-69.

Kodama k. Human fascioliasis: comparison of a fasciolicidal effect of bithionol and praziquantel. Kansenshogaku Zasshi. 1997; 71(11):1162-1167.

Farag HF, Salem A, el-Hifni SA, Kandil M. Bithionol (Bitin) treatment in established fascioliasis in Egyptians. J Trop Med Hyg. 1988; 91(5):240-244.

Sarshad A, Yadegari D, Forghan-Parast K, Haji-Abdolbaghi M. A report on treatment of 31 cases of human fascioliasis with bi-thionol. Paper presented in 1st National Ira-nian Congress of Parasitology and Parasitic Dis-eases. Guilan University of Medical Sciences, Rasht, Iran, 1990; Dec 11-13.

Yadegari D, Talaei H, Massoud J. Clinical trial of triclabendazole on human fascio-lisis: long term follow up. Med J Islamic Repub Iran. 1999; 13(2):89-96.

Talaei H, Emami H, Yadegari D, Nava-Ocampo AA, Massoud J, Azmoudeh M, Mas-Coma S. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in

patients with fascioliasis. Clin Exp Pharma-col Physiol. 2004; 31:777–782.

Nik-Akhtar B, Tabibi V. Metronidazole in fascioliasis: report of four cases. J Trop Med and Hyg. 1977; 80(8):179-80.

Mansour-Ghanaei F, Shafaghi A, Fallah M. The effect of metronidazole in treating hu-man fascioliasis. Med Sci Monit. 2003; 9(10):127-130.

Farid Z, Kumal M, Mansour N. Praziquan-tel and Fasciola hepatica infection. Trans R Soc Trop Med Hyg. 1989; 83(6):813.

Patrick DM, Isaac-Renton J. Praziquantel failure in the treatment of Fasciola hepatica. Canadian J Infect Dis. 1992; 3(1):33-36.

Ishii Y, Nakamura-Uchiyama F, Nawa Y. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole. Parasitol Int. 2002; 51(2):205-209.

Yadegari D, Forghan-Parast K, Assmar M. Survey of praziquantel effect on fascioliasis. Med J Islamic Repub Iran. 1991; 5(1-2):43-44.

Hosseini H, Meshgi B, Fatah-Pour S, Mah-davi A, Nazar-Alipour R. Evaluating triclabendazole and albendazole drug re-sistance in sheep in Guilan Province. Iran Vet J. 2011; 6(4):29-37.

World Health Organization. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control, WHO headquarters, Geneva, Switzerland. 2007; Oct 17-18.

Curtale F, Hassanein YA, Savioli L. Con-trol of human fascioliasis by selective chemotherapy: Design, cost and effect of the first public health, school-based inter-vention implemented in endemic areas of the Nile Delta, Egypt. Trans R Soc Trop Med Hyg. 2005; 99(8):599-609.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.